IRAP

Treatment with Interleukin-1 Receptor Antagonist Protein (IRAP) utilizes progressive gene therapy to combat osteoarthritis in your horse. Interleukin-1 (IL-1) is a type of cytokine and is secreted by many types of cells. A cytokine is a chemical secreted by the cells of the immune system to attack infections and apoptotic (damaged or dying) cells. IL-1 is an important part of the inflammatory response but in the case of your horse's joints, sometimes can be detrimental. The joint fluid carries a protein called interleukin-1, which plays an important role in inflammation and accelerates the deterioration of tissues like joint cartilage. Interleukin-1 Receptor Antagonist Protein (IRAP) blocks IL-1 from binding to tissues and inhibits the damaging consequences of IL-1.

The procedure begins with drawing blood from the horse into a syringe. The syringe is specially prepared with glass beads that stimulate production of the antagonist protein and an anticoagulant. The blood is harvested, incubated and centrifuged to separate the plasma (abundant with IRAP) from the blood. Typically, IRAP treatments are administered for three treatments and the horse can usually return to normal work.

A-Cell

http://www.acell.com/pdf/HorseCare.pdf
ACell is a powder that, when injected into an injured tendon or ligament, provides a matrix or scaffold to stimulate healing.

Platelet Rich Plasma, PRP

Plasma harvested from the horse's own bloodstream is processed to increase the concentration of platelets. The final solution is high in various growth factors  beneficial to healing tendon and ligament injuries.

Shockwave Therapy

This treatment modality is well-recognized for its ability to stimulate the healing process for various orthopedic injuries.

Tildren

This medication, approved for use in humans, has the ability to slow the degenerative process in certain bony injuries. Fairfield Equine is involved in a clinical study to determine the effectiveness of this promising drug.